We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking NAMS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NA

NewAmsterdam Pharma Company N.V. (NAMS) short interest & options flow

NASDAQ

NewAmsterdam Pharma just delivered one of its largest single-week short interest reductions on record. Short interest dropped 14.2% over the week to 10.6% of the free float, a move the editorial brief flags as 2.0 standard deviations below the company's typical weekly change. That unwinding, against a backdrop of continued share price weakness and an upcoming trial interim, is the…

Latest pulse30 Jun 2026

NAMS short interest surges 20.2% in one week to 8.1% of float, driven by biotech volatility and pipeline catalysts.

$20.72+8.03% 1d-1.00% 1w-3.96% 1mClose: 11 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$2.48B
Next earnings
18 Feb 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of NewAmsterdam Pharma Company N.V. (NAMS) share price and short interest (% of free float), six months to November 11, 2026

NAMS news and analysis

RSS

No long-form analysis yet for NAMS. Pulse alerts and the live data picture are available on ORTEX.

Open NAMS on ORTEX →

Want the live picture for NAMS?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NAMS — free to start on ORTEX.

Sign up for free →Open NAMS on ORTEX